This patent seems to cover the use of angiogenic stimuli, together with stem cells for treatment of muscle disorders including disorders associated with the myocardium. This patent may influence the current trials ongoing for treatment of myocardial dysfunction with stem cells and angiogenic stimuli.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.